{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T10:00:44Z","timestamp":1791021644404,"version":"4.1.0"},"reference-count":175,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004391","name":"China Medical University Hospital","doi-asserted-by":"publisher","award":["ASIA-106-51009"],"award-info":[{"award-number":["ASIA-106-51009"]}],"id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004391","name":"China Medical University Hospital","doi-asserted-by":"publisher","award":["ASIA-105-CMUH-07"],"award-info":[{"award-number":["ASIA-105-CMUH-07"]}],"id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004391","name":"China Medical University Hospital","doi-asserted-by":"publisher","award":["ASIA-106-CMUH-14"],"award-info":[{"award-number":["ASIA-106-CMUH-14"]}],"id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.cca.2019.02.016","type":"journal-article","created":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T02:32:56Z","timestamp":1550197976000},"page":"63-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Endometriosis-associated ovarian cancer: What have we learned so far?"],"prefix":"10.1016","volume":"493","author":[{"given":"M.","family":"Herreros-Villanueva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Chieh","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eing-Mei","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7068-1652","authenticated-orcid":false,"given":"Tze-Kiong","family":"Er","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cca.2019.02.016_bb0005","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ygyno.2005.11.033","article-title":"Association between endometriosis and cancer: a comprehensive review and a critical analysis of clinical and epidemiological evidence","volume":"101","author":"Somigliana","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.cca.2019.02.016_bb0010","doi-asserted-by":"crossref","first-page":"179515","DOI":"10.1155\/2014\/179515","article-title":"Theories on the pathogenesis of endometriosis","volume":"2014","author":"Sourial","year":"2014","journal-title":"Int. J. Reprod. Med."},{"issue":"1","key":"10.1016\/j.cca.2019.02.016_bb0015","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.rbmo.2010.03.031","article-title":"Pathogenesis of endometriosis","volume":"21","author":"Robboy","year":"2010","journal-title":"Reprod. BioMed. Online"},{"key":"10.1016\/j.cca.2019.02.016_bb0020","series-title":"Pathology of the Female Reproductive Tract","article-title":"Endometriosis","author":"Robboy","year":"2009"},{"issue":"25","key":"10.1016\/j.cca.2019.02.016_bb0025","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMcp1000274","article-title":"Clinical practice. Endometriosis","volume":"362","author":"Giudice","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2019.02.016_bb0030","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2147\/IJWH.S66824","article-title":"Endometriosis and ovarian cancer: links, risks, and challenges faced","volume":"7","author":"Pavone","year":"2015","journal-title":"Int. J. Women's Health"},{"key":"10.1016\/j.cca.2019.02.016_bb0035","series-title":"Atlas of Endometriosis","author":"Overton","year":"2007"},{"key":"10.1016\/j.cca.2019.02.016_bb0040","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1196\/annals.1434.014","article-title":"Stem cells and the pathogenesis of endometriosis","volume":"1127","author":"Sasson","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"19","key":"10.1016\/j.cca.2019.02.016_bb0045","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1056\/NEJMoa1614814","article-title":"Cancer-associated mutations in endometriosis without cancer","volume":"376","author":"Anglesio","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.cca.2019.02.016_bb0050","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/path.5082","article-title":"Independent development of endometrial epithelium and stroma within the same endometriosis","volume":"245","author":"Noe","year":"2018","journal-title":"J. Pathol."},{"key":"10.1016\/j.cca.2019.02.016_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/archsurg.1925.01120100007001","article-title":"Endometrial carcinoma of the ovary, arising in endometrial tissue in that organ","volume":"10","author":"Sampson","year":"1925","journal-title":"Arch. Surg."},{"issue":"3","key":"10.1016\/j.cca.2019.02.016_bb0060","first-page":"318","article-title":"A histologic study of ovarian endometriosis with emphasis on hyperplastic and atypical changes","volume":"53","author":"Czernobilsky","year":"1979","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.cca.2019.02.016_bb0065","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/jcm7110379","article-title":"Association of pelvic inflammatory disease with risk of endometriosis: a nationwide cohort study involving 141,460 individuals","volume":"7","author":"Tai","year":"2018","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.cca.2019.02.016_bb0070","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1056\/NEJMra0804690","article-title":"Endometriosis","volume":"360","author":"Bulun","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.cca.2019.02.016_bb0075","first-page":"93","article-title":"Metastatic or embolic endometriosis, due to the menstrual dissemination of endometrial tissue into the venous circulation","volume":"3","author":"Sampson","year":"1927","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cca.2019.02.016_bb0080","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0002-9378(15)30003-X","article-title":"Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity","volume":"14","author":"Sampson","year":"1927","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.cca.2019.02.016_bb0085","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1749-6632.2011.05969.x","article-title":"Stem cells in endometrium and their role in the pathogenesis of endometriosis","volume":"1221","author":"Figueira","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"12","key":"10.1016\/j.cca.2019.02.016_bb0090","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1158\/1055-9965.EPI-05-0394","article-title":"Relationship of benign gynecologic diseases to subsequent risk of ovarian and uterine tumors","volume":"14","author":"Brinton","year":"2005","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"10","key":"10.1016\/j.cca.2019.02.016_bb0095","first-page":"1357","article-title":"Risk of epithelial ovarian cancer in relation to benign ovarian conditions and ovarian surgery","volume":"19","author":"Rossing","year":"2008","journal-title":"Cancer Causes Control"},{"issue":"2","key":"10.1016\/j.cca.2019.02.016_bb0100","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1042\/CS20130099","article-title":"Genetic, epigenetic and stem cell alterations in endometriosis: new insights and potential therapeutic perspectives","volume":"126","author":"Forte","year":"2014","journal-title":"Clin. Sci. (Lond.)"},{"issue":"3","key":"10.1016\/j.cca.2019.02.016_bb0105","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ajog.2015.03.044","article-title":"New insights in the pathophysiology of ovarian cancer and implications for screening and prevention","volume":"213","author":"Nezhat","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.cca.2019.02.016_bb0110","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/humupd\/dmv013","article-title":"Endometriosis: a high-risk population for major chronic diseases?","volume":"21","author":"Kvaskoff","year":"2015","journal-title":"Hum. Reprod. Update"},{"issue":"4","key":"10.1016\/j.cca.2019.02.016_bb0115","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1470-2045(11)70404-1","article-title":"Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies","volume":"13","author":"Pearce","year":"2012","journal-title":"Lancet Oncol."},{"issue":"5","key":"10.1016\/j.cca.2019.02.016_bb0120","first-page":"7689","article-title":"Association between ovarian cancer and advanced endometriosis","volume":"15","author":"Matalliotakis","year":"2018","journal-title":"Oncol. Lett."},{"issue":"39","key":"10.1016\/j.cca.2019.02.016_bb0125","doi-asserted-by":"crossref","first-page":"e1633","DOI":"10.1097\/MD.0000000000001633","article-title":"The risk of epithelial ovarian cancer of women with endometriosis may be varied greatly if diagnostic criteria are different: a nationwide population-based cohort study","volume":"94","author":"Lee","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.cca.2019.02.016_bb0130","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1097\/IGC.0000000000000454","article-title":"The risks for ovarian, endometrial, breast, colorectal, and other cancers in women with newly diagnosed endometriosis or adenomyosis: a population-based study","volume":"25","author":"Kok","year":"2015","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"4","key":"10.1016\/j.cca.2019.02.016_bb0135","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.tjog.2014.04.025","article-title":"Endometriosis and the subsequent risk of epithelial ovarian cancer","volume":"53","author":"Chang","year":"2014","journal-title":"Taiwan J. Obstet. Gynecol."},{"key":"10.1016\/j.cca.2019.02.016_bb0140","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3332\/ecancer.2018.803","article-title":"Endometriosis and endometriosis-associated cancers: new insights into the molecular mechanisms of ovarian cancer development","volume":"12","author":"Dawson","year":"2018","journal-title":"Ecancermedicalscience"},{"issue":"2","key":"10.1016\/j.cca.2019.02.016_bb0145","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ygyno.2018.09.001","article-title":"Genomics to immunotherapy of ovarian clear cell carcinoma: unique opportunities for management","volume":"151","author":"Oda","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.cca.2019.02.016_bb0150","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/GRF.0000000000000320","article-title":"Endometriosis-associated ovarian cancers","volume":"60","author":"Anglesio","year":"2017","journal-title":"Clin. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.cca.2019.02.016_bb0155","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-018-0008-5","article-title":"Endometriosis","volume":"4","author":"Zondervan","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"3","key":"10.1016\/j.cca.2019.02.016_bb0160","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/ajmg.c.31410","article-title":"SWI\/SNF chromatin remodeling complexes and cancer","volume":"166C","author":"Biegel","year":"2014","journal-title":"Am. J. Med. Genet. C: Semin. Med. Genet."},{"issue":"16","key":"10.1016\/j.cca.2019.02.016_bb0165","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1008433","article-title":"ARID1A mutations in endometriosis-associated ovarian carcinomas","volume":"363","author":"Wiegand","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"6001","key":"10.1016\/j.cca.2019.02.016_bb0170","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1126\/science.1196333","article-title":"Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma","volume":"330","author":"Jones","year":"2010","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.cca.2019.02.016_bb0175","first-page":"642","article-title":"Loss of ARID1A\/BAF250a expression in ovarian endometriosis and clear cell carcinoma","volume":"5","author":"Xiao","year":"2012","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"19","key":"10.1016\/j.cca.2019.02.016_bb0180","doi-asserted-by":"crossref","first-page":"14754","DOI":"10.18632\/oncotarget.24546","article-title":"Affinity-purified DNA-based mutation profiles of endometriosis-related ovarian neoplasms in Japanese patients","volume":"9","author":"Ishikawa","year":"2018","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.cca.2019.02.016_bb0185","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00109-016-1395-2","article-title":"Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer","volume":"94","author":"Er","year":"2016","journal-title":"J. Mol. Med. (Berl)."},{"issue":"9","key":"10.1016\/j.cca.2019.02.016_bb0190","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3109\/09513590.2014.926325","article-title":"Novel insights on the malignant transformation of endometriosis into ovarian carcinoma","volume":"30","author":"Gadducci","year":"2014","journal-title":"Gynecol. Endocrinol."},{"issue":"4","key":"10.1016\/j.cca.2019.02.016_bb0195","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/modpathol.2011.189","article-title":"Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations","volume":"25","author":"Yamamoto","year":"2012","journal-title":"Mod. Pathol."},{"issue":"2","key":"10.1016\/j.cca.2019.02.016_bb0200","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1586\/egh.11.103","article-title":"Management of advanced gastric cancer","volume":"6","author":"Price","year":"2012","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"issue":"12","key":"10.1016\/j.cca.2019.02.016_bb0205","first-page":"6819","article-title":"Loss of ARID1A, ARID1B, and ARID2 expression during progression of gastric cancer","volume":"35","author":"Aso","year":"2015","journal-title":"Anticancer Res."},{"key":"10.1016\/j.cca.2019.02.016_bb0210","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.35.15_suppl.2588","article-title":"SWI\/SNF complex subunit aberrations in diverse cancers: next-generation sequencing of 539 patients","volume":"35","author":"Groisberg","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.cca.2019.02.016_bb0215","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/ng.903","article-title":"Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma","volume":"43","author":"Li","year":"2011","journal-title":"Nat. Genet."},{"issue":"9","key":"10.1016\/j.cca.2019.02.016_bb0220","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1002\/ijc.27900","article-title":"Recurrent inactivating mutations of ARID2 in non-small cell lung carcinoma","volume":"132","author":"Manceau","year":"2013","journal-title":"Int. J. Cancer"},{"issue":"9","key":"10.1016\/j.cca.2019.02.016_bb0225","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/jjco\/hyt101","article-title":"Inactivating mutations in SWI\/SNF chromatin remodeling genes in human cancer","volume":"43","author":"Oike","year":"2013","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.cca.2019.02.016_bb0230","first-page":"315","article-title":"Recent advances in the ARID family: focusing on roles in human cancer","volume":"7","author":"Lin","year":"2014","journal-title":"Onco. Targets Ther."},{"issue":"3","key":"10.1016\/j.cca.2019.02.016_bb0235","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/ijc.28705","article-title":"Exome sequencing reveals frequent inactivating mutations in ARID1A, ARID1B, ARID2 and ARID4A in microsatellite unstable colorectal cancer","volume":"135","author":"Cajuso","year":"2014","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.cca.2019.02.016_bb0240","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.jhep.2016.12.026","article-title":"ARID2 modulates DNA damage response in human hepatocellular carcinoma cells","volume":"66","author":"Oba","year":"2017","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.cca.2019.02.016_bb0245","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ygyno.2014.02.017","article-title":"mTOR inhibitors and their clinical application in cervical, endometrial and ovarian cancers: a critical review","volume":"133","author":"Husseinzadeh","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.cca.2019.02.016_bb0250","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.2353\/ajpath.2009.081000","article-title":"Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma","volume":"174","author":"Kuo","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cca.2019.02.016_bb0255","doi-asserted-by":"crossref","first-page":"4809751","DOI":"10.1155\/2017\/4809751","article-title":"A review of mTOR pathway inhibitors in gynecologic cancer","volume":"2017","author":"de Melo","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"2","key":"10.1016\/j.cca.2019.02.016_bb0260","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3892\/or.2014.3268","article-title":"The PI3K\/mTOR dual inhibitor NVP-BEZ235 reduces the growth of ovarian clear cell carcinoma","volume":"32","author":"Oishi","year":"2014","journal-title":"Oncol. Rep."},{"issue":"9","key":"10.1016\/j.cca.2019.02.016_bb0265","doi-asserted-by":"crossref","first-page":"18824","DOI":"10.3390\/ijms140918824","article-title":"ARID1A mutations and PI3K\/AKT pathway alterations in endometriosis and endometriosis-associated ovarian carcinomas","volume":"14","author":"Samartzis","year":"2013","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.cca.2019.02.016_bb0270","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/path.2940","article-title":"PIK3CA mutation is an early event in the development of endometriosis-associated ovarian clear cell adenocarcinoma","volume":"225","author":"Yamamoto","year":"2011","journal-title":"J. Pathol."},{"issue":"2","key":"10.1016\/j.cca.2019.02.016_bb0275","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1042\/BJ20070681","article-title":"Effects of oncogenic p110alpha subunit mutations on the lipid kinase activity of phosphoinositide 3-kinase","volume":"409","author":"Carson","year":"2008","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.cca.2019.02.016_bb0280","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ygyno.2017.12.005","article-title":"Genomic landscape of ovarian clear cell carcinoma via whole exome sequencing","volume":"148","author":"Kim","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"8","key":"10.1016\/j.cca.2019.02.016_bb0285","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.humpath.2011.10.009","article-title":"KRAS mutations in ovarian low-grade endometrioid adenocarcinoma: association with concurrent endometriosis","volume":"43","author":"Stewart","year":"2012","journal-title":"Hum. Pathol."},{"issue":"2","key":"10.1016\/j.cca.2019.02.016_bb0290","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00428-014-1599-1","article-title":"Mutational status of KRAS, NRAS, and BRAF in primary clear cell ovarian carcinoma","volume":"465","author":"Zannoni","year":"2014","journal-title":"Virchows Arch."},{"issue":"7","key":"10.1016\/j.cca.2019.02.016_bb0295","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/annonc\/mdg299","article-title":"P21WAF1, P27KIP1, TP53 and C-MYC analysis in 204 ovarian carcinomas treated with platinum-based regimens","volume":"14","author":"Plisiecka-Halasa","year":"2003","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.cca.2019.02.016_bb0300","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/cdd.2014.15","article-title":"Endogenous c-Myc is essential for p53-induced apoptosis in response to DNA damage in vivo","volume":"21","author":"Phesse","year":"2014","journal-title":"Cell Death Differ."},{"issue":"3","key":"10.1016\/j.cca.2019.02.016_bb0305","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/0090-8258(90)90069-W","article-title":"c-myc amplification in ovarian cancer","volume":"38","author":"Baker","year":"1990","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.cca.2019.02.016_bb0310","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1006\/exmp.1999.2259","article-title":"c-myc and chromosome 8 centromere studies of ovarian cancer by interphase FISH","volume":"66","author":"Wang","year":"1999","journal-title":"Exp. Mol. Pathol."},{"issue":"9","key":"10.1016\/j.cca.2019.02.016_bb0315","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.1073\/pnas.93.9.4091","article-title":"Dominant-negative p53 mutations selected in yeast hit cancer hot spots","volume":"93","author":"Brachmann","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.cca.2019.02.016_bb0320","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/pgp.0b013e31802b41a8","article-title":"The role of p53 mutation in the carcinomas arising from endometriosis","volume":"26","author":"Akahane","year":"2007","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"1\u20132","key":"10.1016\/j.cca.2019.02.016_bb0325","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0165-0378(01)00131-0","article-title":"Somatic DNA alterations in endometriosis: high frequency of chromosome 17 and p53 loss in late-stage endometriosis","volume":"55","author":"Bischoff","year":"2002","journal-title":"J. Reprod. Immunol."},{"issue":"3","key":"10.1016\/j.cca.2019.02.016_bb0330","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory","volume":"34","author":"Kurman","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"issue":"7","key":"10.1016\/j.cca.2019.02.016_bb0335","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.humpath.2011.03.003","article-title":"Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer\u2014shifting the paradigm","volume":"42","author":"Kurman","year":"2011","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.cca.2019.02.016_bb0340","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2015.33","article-title":"CTCF as a multifunctional protein in genome regulation and gene expression","volume":"47","author":"Kim","year":"2015","journal-title":"Exp. Mol. Med."},{"issue":"12","key":"10.1016\/j.cca.2019.02.016_bb0345","first-page":"1743","article-title":"A novel sequence-specific DNA binding protein which interacts with three regularly spaced direct repeats of the CCCTC-motif in the 5\u2032-flanking sequence of the chicken c-myc gene","volume":"5","author":"Lobanenkov","year":"1990","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.cca.2019.02.016_bb0350","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.molcel.2009.04.001","article-title":"Epigenetic silencing of the p16(INK4a) tumor suppressor is associated with loss of CTCF binding and a chromatin boundary","volume":"34","author":"Witcher","year":"2009","journal-title":"Mol. Cell"},{"issue":"15","key":"10.1016\/j.cca.2019.02.016_bb0355","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1038\/onc.2009.509","article-title":"Epigenetic regulation of the human p53 gene promoter by the CTCF transcription factor in transformed cell lines","volume":"29","author":"Soto-Reyes","year":"2010","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.cca.2019.02.016_bb0360","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1593\/neo.121948","article-title":"A novel mechanism for CTCF in the epigenetic regulation of Bax in breast cancer cells","volume":"15","author":"Mendez-Catala","year":"2013","journal-title":"Neoplasia"},{"issue":"37","key":"10.1016\/j.cca.2019.02.016_bb0365","doi-asserted-by":"crossref","first-page":"62217","DOI":"10.18632\/oncotarget.19216","article-title":"CTCF promotes epithelial ovarian cancer metastasis by broadly controlling the expression of metastasis-associated genes","volume":"8","author":"Zhao","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.cca.2019.02.016_bb0370","first-page":"1031","article-title":"Novel CTCF mutations in Chinese patients with ovarian endometriosis","volume":"18","author":"Guo","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"5109","key":"10.1016\/j.cca.2019.02.016_bb0375","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1126\/science.8484121","article-title":"Clues to the pathogenesis of familial colorectal cancer","volume":"260","author":"Aaltonen","year":"1993","journal-title":"Science"},{"issue":"5109","key":"10.1016\/j.cca.2019.02.016_bb0380","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.8484122","article-title":"Microsatellite instability in cancer of the proximal colon","volume":"260","author":"Thibodeau","year":"1993","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.cca.2019.02.016_bb0385","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nrc3816","article-title":"Hypermutation in human cancer genomes: footprints and mechanisms","volume":"14","author":"Roberts","year":"2014","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.cca.2019.02.016_bb0390","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3889\/oamjms.2017.003","article-title":"Mismatch repair proteins and microsatellite instability in colorectal carcinoma (MLH1, MSH2, MSH6 and PMS2): histopathological and immunohistochemical study","volume":"5","author":"Ismael","year":"2017","journal-title":"Open Access Maced J. Med. Sci."},{"issue":"11","key":"10.1016\/j.cca.2019.02.016_bb0395","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1002\/1097-0142(20011201)92:11<2829::AID-CNCR10094>3.0.CO;2-3","article-title":"Microsatellite instability, MLH-1 promoter hypermethylation, and frameshift mutations at coding mononucleotide repeat microsatellites in ovarian tumors","volume":"92","author":"Gras","year":"2001","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.cca.2019.02.016_bb0400","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00404-017-4563-x","article-title":"Prognostic values of DNA mismatch repair genes in ovarian cancer patients treated with platinum-based chemotherapy","volume":"297","author":"Zhao","year":"2018","journal-title":"Arch. Gynecol. Obstet."},{"issue":"2","key":"10.1016\/j.cca.2019.02.016_bb0405","first-page":"1867","article-title":"Mismatch repair system in endometriotic tissue and eutopic endometrium of unaffected women","volume":"8","author":"Grassi","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"1","key":"10.1016\/j.cca.2019.02.016_bb0410","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ygyno.2018.02.009","article-title":"Mismatch repair deficiency is associated with MSI phenotype, increased tumor-infiltrating lymphocytes and PD-L1 expression in immune cells in ovarian cancer","volume":"149","author":"Xiao","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.cca.2019.02.016_bb0415","doi-asserted-by":"crossref","first-page":"e1277308","DOI":"10.1080\/2162402X.2016.1277308","article-title":"Clear cell ovarian cancers with microsatellite instability: A unique subset of ovarian cancers with increased tumor-infiltrating lymphocytes and PD-1\/PD-L1 expression","volume":"6","author":"Howitt","year":"2017","journal-title":"Oncoimmunology"},{"issue":"3","key":"10.1016\/j.cca.2019.02.016_bb0420","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.cell.2009.10.006","article-title":"Serine\/threonine phosphatases: mechanism through structure","volume":"139","author":"Shi","year":"2009","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.cca.2019.02.016_bb0425","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1091\/mbc.e06-12-1152","article-title":"Functional interaction of Aurora-A and PP2A during mitosis","volume":"18","author":"Horn","year":"2007","journal-title":"Mol. Biol. Cell"},{"issue":"21","key":"10.1016\/j.cca.2019.02.016_bb0430","doi-asserted-by":"crossref","first-page":"5696","DOI":"10.1128\/MCB.00191-09","article-title":"Protein phosphatase 2A-dependent dephosphorylation of replication protein A is required for the repair of DNA breaks induced by replication stress","volume":"29","author":"Feng","year":"2009","journal-title":"Mol. Cell. Biol."},{"issue":"6","key":"10.1016\/j.cca.2019.02.016_bb0435","doi-asserted-by":"crossref","first-page":"289","DOI":"10.5483\/BMBRep.2013.46.6.041","article-title":"PP2A function toward mitotic kinases and substrates during the cell cycle","volume":"46","author":"Jeong","year":"2013","journal-title":"BMB Rep."},{"issue":"4","key":"10.1016\/j.cca.2019.02.016_bb0440","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.ajpath.2011.01.009","article-title":"Somatic mutations of PPP2R1A in ovarian and uterine carcinomas","volume":"178","author":"Shih Ie","year":"2011","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.cca.2019.02.016_bb0445","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.3892\/mmr.2013.1416","article-title":"Infrequent mutations of the PPP2R1A and PPP2R1B genes in patients with ovarian cancer","volume":"7","author":"Wang","year":"2013","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.cca.2019.02.016_bb0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mrfmmm.2018.03.001","article-title":"The presence of KRAS, PPP2R1A and ARID1A mutations in 101 Chinese samples with ovarian endometriosis","volume":"809","author":"Zou","year":"2018","journal-title":"Mutat. Res."},{"issue":"11","key":"10.1016\/j.cca.2019.02.016_bb0455","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/S1470-2045(11)70282-0","article-title":"Antioxidants and cancer","volume":"12","author":"Stebbing","year":"2011","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.cca.2019.02.016_bb0460","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1177\/1534735416681639","article-title":"Potential contributions of antioxidants to cancer therapy: immunomodulation and radiosensitization","volume":"17","author":"Thyagarajan","year":"2018","journal-title":"Integr. Cancer Ther."},{"issue":"11","key":"10.1016\/j.cca.2019.02.016_bb0465","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.jnutbio.2010.09.009","article-title":"The protective effects of nutritional antioxidant therapy on Ehrlich solid tumor-bearing mice depend on the type of antioxidant therapy chosen: histology, genotoxicity and hematology evaluations","volume":"22","author":"Miranda-Vilela","year":"2011","journal-title":"J. Nutr. Biochem."},{"issue":"1","key":"10.1016\/j.cca.2019.02.016_bb0470","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1158\/1078-0432.CCR-07-1614","article-title":"Contents of endometriotic cysts, especially the high concentration of free iron, are a possible cause of carcinogenesis in the cysts through the iron-induced persistent oxidative stress","volume":"14","author":"Yamaguchi","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cca.2019.02.016_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.semcancer.2018.07.009","article-title":"A promising new approach to cancer therapy: targeting iron metabolism in cancer stem cells","author":"El Hout","year":"2018","journal-title":"Semin. Cancer Biol."},{"issue":"4","key":"10.1016\/j.cca.2019.02.016_bb0480","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0104-4230(11)70093-8","article-title":"Environmental factors and endometriosis","volume":"57","author":"Bellelis","year":"2011","journal-title":"Rev. Assoc. Med. Bras. (1992)"},{"issue":"1","key":"10.1016\/j.cca.2019.02.016_bb0485","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/MED.0b013e328320d560","article-title":"The influence of endocrine disruptors on pubertal timing","volume":"16","author":"Jacobson-Dickman","year":"2009","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"2","key":"10.1016\/j.cca.2019.02.016_bb0490","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/humrep\/12.2.373","article-title":"Dioxin concentrations in women with endometriosis","volume":"12","author":"Mayani","year":"1997","journal-title":"Hum. Reprod."},{"issue":"9\u201311","key":"10.1016\/j.cca.2019.02.016_bb0495","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0045-6535(99)00376-8","article-title":"Seveso Women's Health Study: a study of the effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on reproductive health","volume":"40","author":"Eskenazi","year":"2000","journal-title":"Chemosphere"},{"issue":"2","key":"10.1016\/j.cca.2019.02.016_bb0500","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/toxsci\/70.2.161","article-title":"Environmental dioxins and endometriosis","volume":"70","author":"Rier","year":"2002","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.cca.2019.02.016_bb0505","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12978-018-0506-7","article-title":"A review of the risk factors, genetics and treatment of endometriosis in Chinese women: a comparative update","volume":"15","author":"Dai","year":"2018","journal-title":"Reprod. Health"},{"issue":"10","key":"10.1016\/j.cca.2019.02.016_bb0510","doi-asserted-by":"crossref","first-page":"e3420","DOI":"10.1371\/journal.pone.0003420","article-title":"An analysis of human microRNA and disease associations","volume":"3","author":"Lu","year":"2008","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.cca.2019.02.016_bb0515","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4331\/wjbc.v8.i1.45","article-title":"Role of microRNAs in translation regulation and cancer","volume":"8","author":"Oliveto","year":"2017","journal-title":"World J. Biol. Chem."},{"issue":"18","key":"10.1016\/j.cca.2019.02.016_bb0520","doi-asserted-by":"crossref","first-page":"8699","DOI":"10.1158\/0008-5472.CAN-07-1936","article-title":"MicroRNA signatures in human ovarian cancer","volume":"67","author":"Iorio","year":"2007","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.cca.2019.02.016_bb0525","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4149\/neo_2014_005","article-title":"MicroRNA-191 correlates with poor prognosis of colorectal carcinoma and plays multiple roles by targeting tissue inhibitor of metalloprotease 3","volume":"61","author":"Qin","year":"2014","journal-title":"Neoplasma"},{"issue":"47","key":"10.1016\/j.cca.2019.02.016_bb0530","doi-asserted-by":"crossref","first-page":"76713","DOI":"10.18632\/oncotarget.11536","article-title":"Up-regulation of ribosome biogenesis by MIR196A2 genetic variation promotes endometriosis development and progression","volume":"7","author":"Chang","year":"2016","journal-title":"Oncotarget"},{"issue":"1\u20132","key":"10.1016\/j.cca.2019.02.016_bb0535","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.mrfmmm.2011.05.004","article-title":"Environmental chemicals and microRNAs","volume":"714","author":"Hou","year":"2011","journal-title":"Mutat. Res."},{"key":"10.1016\/j.cca.2019.02.016_bb0540","article-title":"Towards the understanding of microRNA and environmental factor interactions and their relationships to human diseases","volume":"2","author":"Qiu","year":"2012","journal-title":"Sci. Rep. UK"},{"issue":"3","key":"10.1016\/j.cca.2019.02.016_bb0545","first-page":"3359","article-title":"Role of miR449b3p in endometriosis via effects on endometrial stromal cell proliferation and angiogenesis","volume":"18","author":"Liu","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"3","key":"10.1016\/j.cca.2019.02.016_bb0550","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/emmm.201100200","article-title":"A polymorphism in a let-7 microRNA binding site of KRAS in women with endometriosis","volume":"4","author":"Grechukhina","year":"2012","journal-title":"EMBO Mol. Med."},{"issue":"3","key":"10.1016\/j.cca.2019.02.016_bb0555","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.fertnstert.2016.05.020","article-title":"Aromatase inhibitor regulates let-7 expression and let-7f-induced cell migration in endometrial cells from women with endometriosis","volume":"106","author":"Cho","year":"2016","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.cca.2019.02.016_bb0560","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.13807","article-title":"microRNA Let-7b: A Novel treatment for endometriosis","author":"Sahin","year":"2018","journal-title":"J. Cell. Mol. Med."},{"issue":"3","key":"10.1016\/j.cca.2019.02.016_bb0565","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/path.4295","article-title":"miRNA-199a-5p regulates VEGFA in endometrial mesenchymal stem cells and contributes to the pathogenesis of endometriosis","volume":"232","author":"Hsu","year":"2014","journal-title":"J. Pathol."},{"key":"10.1016\/j.cca.2019.02.016_bb0570","article-title":"miR-191 modulates malignant transformation of endometriosis through regulating TIMP3","volume":"21","author":"Dong","year":"2015","journal-title":"Med. Sci. Monit."},{"issue":"5","key":"10.1016\/j.cca.2019.02.016_bb0575","first-page":"4933","article-title":"MiR-191 inhibits TNF-alpha induced apoptosis of ovarian endometriosis and endometrioid carcinoma cells by targeting DAPK1","volume":"8","author":"Tian","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"6","key":"10.1016\/j.cca.2019.02.016_bb0580","first-page":"3734","article-title":"MiR-381 regulates cell motility, growth and colony formation through PIK3CA in endometriosis-associated clear cell and endometrioid ovarian cancer","volume":"40","author":"Hsu","year":"2018","journal-title":"Oncol. Rep."},{"issue":"21","key":"10.1016\/j.cca.2019.02.016_bb0585","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","article-title":"Tumor angiogenesis: therapeutic implications","volume":"285","author":"Folkman","year":"1971","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.cca.2019.02.016_bb0590","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","article-title":"Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis","volume":"86","author":"Hanahan","year":"1996","journal-title":"Cell"},{"issue":"1\u20132","key":"10.1016\/j.cca.2019.02.016_bb0595","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0022-1759(02)00420-9","article-title":"Analysis of the role of chemokines in angiogenesis","volume":"273","author":"Bernardini","year":"2003","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.cca.2019.02.016_bb0600","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1749-6632.2002.tb02770.x","article-title":"Local cytokines in endometrial tissue: the role of interleukin-8 in the pathogenesis of endometriosis","volume":"955","author":"Arici","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.cca.2019.02.016_bb0605","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0015-0282(16)56447-4","article-title":"Growth factors and growth modulators in human uterine endometrium: their potential relevance to reproductive medicine","volume":"61","author":"Giudice","year":"1994","journal-title":"Fertil. Steril."},{"issue":"2","key":"10.1016\/j.cca.2019.02.016_bb0610","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1074\/jbc.271.2.736","article-title":"Interleukin 6 induces the expression of vascular endothelial growth factor","volume":"271","author":"Cohen","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.cca.2019.02.016_bb0615","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1093\/humrep\/dem149","article-title":"Expression of angiogenic factors in endometriosis: relationship to fibrinolytic and metalloproteinase systems","volume":"22","author":"Gilabert-Estelles","year":"2007","journal-title":"Hum. Reprod."},{"issue":"11","key":"10.1016\/j.cca.2019.02.016_bb0620","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.humpath.2004.07.020","article-title":"Vascular endothelial growth factor A and C gene expression in endometriosis","volume":"35","author":"Takehara","year":"2004","journal-title":"Hum. Pathol."},{"issue":"4","key":"10.1016\/j.cca.2019.02.016_bb0625","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1080\/00016340500432556","article-title":"Peritoneal fluid and serum levels of hepatocyte growth factor may predict the activity of endometriosis","volume":"85","author":"Khan","year":"2006","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"5","key":"10.1016\/j.cca.2019.02.016_bb0630","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/humrep\/16.5.945","article-title":"Erythropoietin concentrations are elevated in the peritoneal fluid of women with endometriosis","volume":"16","author":"Matsuzaki","year":"2001","journal-title":"Hum. Reprod."},{"issue":"1","key":"10.1016\/j.cca.2019.02.016_bb0635","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.fertnstert.2003.11.043","article-title":"Elevated angiogenin levels in the peritoneal fluid of women with endometriosis correlate with the extent of the disorder","volume":"82","author":"Suzumori","year":"2004","journal-title":"Fertil. Steril."},{"issue":"1","key":"10.1016\/j.cca.2019.02.016_bb0640","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0015-0282(02)03189-8","article-title":"Marked elevation of macrophage migration inhibitory factor in the peritoneal fluid of women with endometriosis","volume":"78","author":"Kats","year":"2002","journal-title":"Fertil. Steril."},{"issue":"2","key":"10.1016\/j.cca.2019.02.016_bb0645","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/gye.16.2.137.141","article-title":"Chemokine growth-regulated-alpha: a possible role in the pathogenesis of endometriosis","volume":"16","author":"Szamatowicz","year":"2002","journal-title":"Gynecol. Endocrinol."},{"issue":"1","key":"10.1016\/j.cca.2019.02.016_bb0650","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0015-0282(00)01656-3","article-title":"Tumor necrosis factor-alpha but not interleukin-1 beta or interleukin-8 concentrations correlate with angiogenic activity of peritoneal fluid from patients with minimal to mild endometriosis","volume":"75","author":"Maas","year":"2001","journal-title":"Fertil. Steril."},{"issue":"3","key":"10.1016\/j.cca.2019.02.016_bb0655","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/GRF.0000000000000298","article-title":"A review of the epigenetic contributions to endometriosis","volume":"60","author":"Grimstad","year":"2017","journal-title":"Clin. Obstet. Gynecol."},{"key":"10.1016\/j.cca.2019.02.016_bb0660","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.gore.2017.03.007","article-title":"Epigenetic therapy for the treatment of epithelial ovarian cancer: a clinical review","volume":"20","author":"Smith","year":"2017","journal-title":"Gynecol. Oncol. Rep."},{"key":"10.1016\/j.cca.2019.02.016_bb0665","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fonc.2014.00071","article-title":"Molecular epigenetics in the management of ovarian cancer: are we investigating a rational clinical promise?","volume":"4","author":"Nguyen","year":"2014","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.cca.2019.02.016_bb0670","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.3892\/or.2014.3524","article-title":"RUNX3 is inactivated by promoter hypermethylation in malignant transformation of ovarian endometriosis","volume":"32","author":"Guo","year":"2014","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.cca.2019.02.016_bb0675","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00404-011-1922-x","article-title":"Epigenetic inactivation of hMLH1 in the malignant transformation of ovarian endometriosis","volume":"285","author":"Ren","year":"2012","journal-title":"Arch. Gynecol. Obstet."},{"issue":"1","key":"10.1016\/j.cca.2019.02.016_bb0680","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000445293","article-title":"Aberrant methylation of the E-cadherin gene promoter region in endometrium and ovarian endometriotic cysts of patients with ovarian endometriosis","volume":"82","author":"Li","year":"2017","journal-title":"Gynecol. Obstet. Investig."},{"key":"10.1016\/j.cca.2019.02.016_bb0685","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1757-2215-7-73","article-title":"Identification of differentially methylated genes in the malignant transformation of ovarian endometriosis","volume":"7","author":"Ren","year":"2014","journal-title":"J. Ovarian Res."},{"issue":"4","key":"10.1016\/j.cca.2019.02.016_bb0690","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/ijc.10715","article-title":"Possible involvement of hMLH1, p16(INK4a) and PTEN in the malignant transformation of endometriosis","volume":"102","author":"Martini","year":"2002","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.cca.2019.02.016_bb0695","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","article-title":"Cancer epigenetics: from mechanism to therapy","volume":"150","author":"Dawson","year":"2012","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.cca.2019.02.016_bb0700","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.molonc.2007.01.001","article-title":"The role of histone deacetylases (HDACs) in human cancer","volume":"1","author":"Ropero","year":"2007","journal-title":"Mol. Oncol."},{"issue":"4","key":"10.1016\/j.cca.2019.02.016_bb0705","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1080\/00313020902884451","article-title":"Expression and prognostic significance of SIRT1 in ovarian epithelial tumours","volume":"41","author":"Jang","year":"2009","journal-title":"Pathology"},{"key":"10.1016\/j.cca.2019.02.016_bb0710","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev-immunol-031210-101324","article-title":"Natural innate and adaptive immunity to cancer","volume":"29","author":"Vesely","year":"2011","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.cca.2019.02.016_bb0715","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2017.05.031","article-title":"Endometrial receptivity in the eutopic endometrium of women with endometriosis: it is affected, and let me show you why","volume":"108","author":"Lessey","year":"2017","journal-title":"Fertil. Steril."},{"issue":"5","key":"10.1016\/j.cca.2019.02.016_bb0720","doi-asserted-by":"crossref","first-page":"e1002732","DOI":"10.1080\/2162402X.2014.1002732","article-title":"Chronic inflammation in endometriosis and endometriosis-associated ovarian cancer: new roles for the \u201cold\u201d complement pathway","volume":"4","author":"Edwards","year":"2015","journal-title":"Oncoimmunology"},{"issue":"8","key":"10.1016\/j.cca.2019.02.016_bb0725","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10080261","article-title":"The endometriotic tumor microenvironment in ovarian cancer","volume":"10","author":"Wendel","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.cca.2019.02.016_bb0730","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/aji.12206","article-title":"Expression of natural cytotoxicity receptors on peritoneal fluid natural killer cell and cytokine production by peritoneal fluid natural killer cell in women with endometriosis","volume":"71","author":"Funamizu","year":"2014","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.cca.2019.02.016_bb0735","doi-asserted-by":"crossref","first-page":"795976","DOI":"10.1155\/2015\/795976","article-title":"Pathophysiology and immune dysfunction in endometriosis","volume":"2015","author":"Ahn","year":"2015","journal-title":"Biomed. Res. Int."},{"issue":"12","key":"10.1016\/j.cca.2019.02.016_bb0740","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nri2873","article-title":"Sterile inflammation: sensing and reacting to damage","volume":"10","author":"Chen","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"5089","key":"10.1016\/j.cca.2019.02.016_bb0745","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1126\/science.1281554","article-title":"Interleukin-8 as a macrophage-derived mediator of angiogenesis","volume":"258","author":"Koch","year":"1992","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.cca.2019.02.016_bb0750","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1172\/JCI118815","article-title":"Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids","volume":"98","author":"McLaren","year":"1996","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.cca.2019.02.016_bb0755","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1093\/humrep\/dep071","article-title":"Dendritic cell populations in the eutopic and ectopic endometrium of women with endometriosis","volume":"24","author":"Schulke","year":"2009","journal-title":"Hum. Reprod."},{"issue":"10","key":"10.1016\/j.cca.2019.02.016_bb0760","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1177\/1933719114525267","article-title":"Dendritic cells attenuate the early establishment of endometriosis-like lesions in a murine model","volume":"21","author":"Stanic","year":"2014","journal-title":"Reprod. Sci."},{"issue":"4","key":"10.1016\/j.cca.2019.02.016_bb0765","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.rbmo.2013.12.011","article-title":"The development of endometriosis in a murine model is dependent on the presence of dendritic cells","volume":"28","author":"Pencovich","year":"2014","journal-title":"Reprod. BioMed. Online"},{"issue":"10","key":"10.1016\/j.cca.2019.02.016_bb0770","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1093\/oxfordjournals.humrep.a135765","article-title":"Peritoneal natural-killer cytotoxicity and Cd25(+)Cd3(+) lymphocyte subpopulation are decreased in women with stage Iii-Iv endometriosis","volume":"10","author":"Ho","year":"1995","journal-title":"Hum. Reprod."},{"issue":"2","key":"10.1016\/j.cca.2019.02.016_bb0775","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/jog.13559","article-title":"Involvement of immune cells in the pathogenesis of endometriosis","volume":"44","author":"Izumi","year":"2018","journal-title":"J. Obstet. Gynaecol. Res."},{"issue":"6","key":"10.1016\/j.cca.2019.02.016_bb0780","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.4049\/jimmunol.1501138","article-title":"IL-17A contributes to the pathogenesis of endometriosis by triggering proinflammatory cytokines and angiogenic growth factors","volume":"195","author":"Ahn","year":"2015","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.cca.2019.02.016_bb0785","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0015-0282(16)60185-1","article-title":"Tumor necrosis factor in peritoneal fluid of women undergoing laparoscopic surgery","volume":"50","author":"Eisermann","year":"1988","journal-title":"Fertil. Steril."},{"issue":"2","key":"10.1016\/j.cca.2019.02.016_bb0790","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1600-0897.2012.01147.x","article-title":"Imbalance in cytokines from interleukin-1 family - role in pathogenesis of endometriosis","volume":"68","author":"Sikora","year":"2012","journal-title":"Am. J. Reprod. Immunol."},{"issue":"3","key":"10.1016\/j.cca.2019.02.016_bb0795","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0002-9378(97)70553-2","article-title":"Increased interleukin-6 levels in peritoneal fluid of infertile patients with active endometriosis","volume":"176","author":"Harada","year":"1997","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.cca.2019.02.016_bb0800","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/S0002-9378(96)70600-2","article-title":"Increased levels of interleukin-6 and interleukin-10 in the peritoneal fluid of patients with endometriosis","volume":"174","author":"Punnonen","year":"1996","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.cca.2019.02.016_bb0805","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ajog.2005.12.010","article-title":"PAPP-A and osteoprotegerin, together with interleukin-8 and RANTES, are elevated in the peritoneal fluid of women with endometriosis","volume":"195","author":"Bersinger","year":"2006","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.cca.2019.02.016_bb0810","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1034\/j.1600-0897.2003.00037.x","article-title":"Concentrations of interferon-gamma-induced protein-10 (IP-10), an antiangiogenic substance, are decreased in peritoneal fluid of women with advanced endometriosis","volume":"50","author":"Yoshino","year":"2003","journal-title":"Am. J. Reprod. Immunol."},{"issue":"2","key":"10.1016\/j.cca.2019.02.016_bb0815","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0015-0282(16)60062-6","article-title":"Characterization of leukocyte subpopulations in the peritoneal fluid of women with endometriosis","volume":"50","author":"Hill","year":"1988","journal-title":"Fertil. Steril."},{"issue":"2","key":"10.1016\/j.cca.2019.02.016_bb0820","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1096\/fj.07-9034com","article-title":"Dendritic cells support angiogenesis and promote lesion growth in a murine model of endometriosis","volume":"22","author":"Fainaru","year":"2008","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.cca.2019.02.016_bb0825","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/aji.12408","article-title":"Natural killer cells: key players in endometriosis","volume":"74","author":"Thiruchelvam","year":"2015","journal-title":"Am. J. Reprod. Immunol."},{"issue":"3","key":"10.1016\/j.cca.2019.02.016_bb0830","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/humrep\/17.3.595","article-title":"Modulation of neutrophil apoptosis by plasma and peritoneal fluid from patients with advanced endometriosis","volume":"17","author":"Kwak","year":"2002","journal-title":"Hum. Reprod."},{"issue":"23","key":"10.1016\/j.cca.2019.02.016_bb0835","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.1158\/1078-0432.CCR-14-1338","article-title":"Complement pathway is frequently altered in endometriosis and endometriosis-associated ovarian cancer","volume":"20","author":"Suryawanshi","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.cca.2019.02.016_bb0840","first-page":"177","article-title":"Next-generation sequencing for cancer diagnostics: a practical perspective","volume":"32","author":"Meldrum","year":"2011","journal-title":"Clin. Biochem. Rev."},{"issue":"9","key":"10.1016\/j.cca.2019.02.016_bb0845","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.6004\/jnccn.2016.0123","article-title":"Next-generation sequencing: role in gynecologic cancers","volume":"14","author":"Evans","year":"2016","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.cca.2019.02.016_bb0850","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-017-3054-6","article-title":"Tracking the origin of simultaneous endometrial and ovarian cancer by next-generation sequencing - a case report","volume":"17","author":"Valtcheva","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cca.2019.02.016_bb0855","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/jpm8030030","article-title":"The role of next-generation sequencing in precision medicine: a review of outcomes in oncology","volume":"8","author":"Morash","year":"2018","journal-title":"J. Pers. Med."},{"issue":"8","key":"10.1016\/j.cca.2019.02.016_bb0860","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1080\/17512433.2018.1504677","article-title":"Overview of precision oncology trials: challenges and opportunities","volume":"11","author":"Fountzilas","year":"2018","journal-title":"Expert. Rev. Clin. Pharmacol."},{"issue":"22","key":"10.1016\/j.cca.2019.02.016_bb0865","doi-asserted-by":"crossref","first-page":"6008","DOI":"10.1093\/hmg\/ddu330","article-title":"Whole-exome sequencing of endometriosis identifies frequent alterations in genes involved in cell adhesion and chromatin-remodeling complexes","volume":"23","author":"Li","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"7","key":"10.1016\/j.cca.2019.02.016_bb0870","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.celrep.2018.07.037","article-title":"Clonal expansion and diversification of cancer-associated mutations in endometriosis and normal endometrium","volume":"24","author":"Suda","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.cca.2019.02.016_bb0875","article-title":"Iatrogenic endometriosis harbors somatic cancer-driver mutations","author":"Lac","year":"2018","journal-title":"Hum. Reprod."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898119300683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898119300683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:48:06Z","timestamp":1757861286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898119300683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":175,"alternative-id":["S0009898119300683"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2019.02.016","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endometriosis-associated ovarian cancer: What have we learned so far?","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2019.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}